Radiolabeling, Quality Control, and Immunoassays
Radiolabeling, Quality Control, and Immunoassays
批准号:
7728852
负责人:
HABIBE KARACAY
金额:
$12.78万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2009-07-31
关键词:
90YAntibodiesBiological AssayBloodClinical TrialsCore FacilityCountDataDoseDrug KineticsEnsureEquipmentEquipment and supply inventoriesExclusionExtramural ActivitiesHandHigh Pressure Liquid ChromatographyImmunoassayIsotope LabelingIsotopesLabelLaboratoriesMaintenanceMethodsNew JerseyNumbersParticipantPeptidesPlasmaPreparationProceduresProcessProduct LabelingQuality ControlRadioactive WasteRadioactivityRadioimmunoconjugateRadiolabeledReagentRecordsRegulationReportingResearch PersonnelRunningSamplingSeriesSerumServicesShippingShipsSiteSpecific qualifier valueSpecimenTestingTimeUrineWaste Productsclinical research sitecomputerized data processingdaydosimetryexperienceimmunoreactivityprogramsquality assuranceradiotracersize
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Radiolabeling, Quality Assurance, and Immunoassay Core will provide a variety of services for the
participants of this Program Project. This Core Facility has been providing these same services to CMMI
investigators for 20 years. The primary responsibility of this core involves the preparation of radiolabeled
agents for investigators. This includes the processing, receipt, preparation, quality assurance and disposal of
the radiolabeled materials. This laboratory has experience in preparing radiolabeled antibodies and peptides
with 1311,1251,123I, " V 90Y, 188Re, 99mTc, 212Bi, and 67Ga. Each product that is produced undergoes a series
of quality assurance checks, including ITLC, size-exclusion HPLC, and Immunoreactivity determinations.
All equipment used in this laboratory is calibrated regularly and all procedures are performed under SOPs.
This laboratory also produces radiolabeled investigational agents for a number of INDs, and has experience
in developing procedures to ensure product stability when shipped to extramural investigational sites. This
core is also involved in the processing of blood and urine samples used for pharmacokinetic analysis, as well
as plasma samples for anti-antibody assays. This Core will be utilized by Projects 1,2, and 4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMPROVING TUMOR RADIOIMMUNOTHERAPY BY PNA PRETARGETING
-
批准号:2645330
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1998
-
负责人:HABIBE KARACAY
-
依托单位:
海外基金